Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the …

DA Calhoun, D Jones, S Textor, DC Goff, TP Murphy… - …, 2008 - Am Heart Assoc
Resistant hypertension is a common clinical problem faced by both primary care clinicians
and specialists. While the exact prevalence of resistant hypertension is unknown, clinical …

Preserving renal function in adults with hypertension and diabetes: a consensus approach

GL Bakris, M Williams, L Dworkin, WJ Elliott… - American journal of …, 2000 - Elsevier
Over 11 million Americans have both diabetes and hypertension—comorbid diseases that
strongly predispose people to both renal as well as cardiovascular (CV) injury. Hypertension …

Resistant hypertension: an overview of evaluation and treatment

PA Sarafidis, GL Bakris - Journal of the American College of Cardiology, 2008 - jacc.org
Resistant hypertension is defined as failure to achieve goal blood pressure (BP) when a
patient adheres to the maximum tolerated doses of 3 antihypertensive drugs including a …

Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability

BL Carter, ME Ernst, JD Cohen - Hypertension, 2004 - Am Heart Assoc
Thiazide diuretics are one of the preferred pharmacologic treatments for hypertension.
Hydrochlorothiazide and chlorthalidone have been the 2 most commonly used diuretics in …

Resistant hypertension revisited: a comparison of two university-based cohorts

JP Garg, WJ Elliott, A Folker, M Izhar… - American journal of …, 2005 - academic.oup.com
Background: More than a decade ago, we found that a suboptimal medication regimen was
the leading cause of resistant hypertension (RH) among patients referred to a tertiary care …

Resistant or difficult-to-control hypertension

M Moser, JF Setaro - New England Journal of Medicine, 2006 - Mass Medical Soc
A 70-year-old woman with a long-standing history of hypertension comes for follow-up. Her
medications include atenolol (100 mg daily), hydrochlorothiazide (12.5 mg daily), lisinopril …

Management of glomerular proteinuria: a commentary

WA Wilmer, BH Rovin, CJ Hebert, SV Rao… - Journal of the …, 2003 - journals.lww.com
It is widely accepted that proteinuria reduction is an appropriate therapeutic goal in chronic
proteinuric kidney disease. Based on large randomized controlled clinical trials (RCT), ACE …

[图书][B] Clinical guidelines for the management of hypertension

World Health Organization - 2005 - apps.who.int
The World Health Organization has estimated that high blood pressure causes one in every
eight deaths, making hypertension the third leading killer in the world. In the Eastern …

Resistant hypertension: mechanisms and treatment

AY Hwang, E Dietrich, CJ Pepine, SM Smith - Current Hypertension …, 2017 - Springer
Abstract Purpose of Review Emerging evidence suggests that multiple mechanisms may be
responsible for the development of treatment-resistant hypertension (TRH). This review aims …

Clinical pharmacokinetics of vasodilators: part I

R Kirsten, K Nelson, D Kirsten, B Heintz - Clinical pharmacokinetics, 1998 - Springer
Understanding the mechanism of action and the pharmacokinetic properties of vasodilatory
drugs facilitates optimal use in clinical practice. It should be kept in mind that a drug belongs …